| K-number | K802131 |
| Device name | CYBREX LIDOCAINE |
| Applicant | Abbott Laboratories |
| Product code | KLR |
| Device class | Class II |
| Decision date | Oct 31, 1980 |
| Decision | Substantially Equivalent |
| Regulation | 862.3555 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov